555 related articles for article (PubMed ID: 15066713)
1. Performance characteristics of the Cozart RapiScan Oral Fluid Drug Testing System for opiates in comparison to ELISA and GC/MS following controlled codeine administration.
Kacinko SL; Barnes AJ; Kim I; Moolchan ET; Wilson L; Cooper GA; Reid C; Baldwin D; Hand CW; Huestis MA
Forensic Sci Int; 2004 Apr; 141(1):41-8. PubMed ID: 15066713
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity, specificity, and efficiency in detecting opiates in oral fluid with the Cozart Opiate Microplate EIA and GC-MS following controlled codeine administration.
Barnes AJ; Kim I; Schepers R; Moolchan ET; Wilson L; Cooper G; Reid C; Hand C; Huestis MA
J Anal Toxicol; 2003 Oct; 27(7):402-7. PubMed ID: 14606992
[TBL] [Abstract][Full Text] [Related]
3. Cozart RapiScan Oral Fluid Drug Testing System: an evaluation of sensitivity, specificity, and efficiency for cocaine detection compared with ELISA and GC-MS following controlled cocaine administration.
Kolbrich EA; Kim I; Barnes AJ; Moolchan ET; Wilson L; Cooper GA; Reid C; Baldwin D; Hand CW; Huestis MA
J Anal Toxicol; 2003 Oct; 27(7):407-11. PubMed ID: 14606993
[TBL] [Abstract][Full Text] [Related]
4. Validation of the Cozart microplate EIA for analysis of opiates in oral fluid.
Cooper G; Wilson L; Reid C; Baldwin D; Hand C; Spiehler V
Forensic Sci Int; 2005 Nov; 154(2-3):240-6. PubMed ID: 16182972
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Cozart RapiScan drug test system for opiates and cocaine in oral fluid.
Cooper G; Wilson L; Reid C; Main L; Hand C
Forensic Sci Int; 2005 Jun; 150(2-3):239-43. PubMed ID: 15944065
[TBL] [Abstract][Full Text] [Related]
6. Validation of the Cozart Amphetamine Microplate EIA for the analysis of amphetamines in oral fluid.
Cooper G; Wilson L; Reid C; Hand C; Spiehler V
Forensic Sci Int; 2006 Jun; 159(2-3):104-12. PubMed ID: 16115742
[TBL] [Abstract][Full Text] [Related]
7. Comparison of GC-MS and EIA results for the analysis of methadone in oral fluid.
Cooper G; Wilson L; Reid C; Baldwin D; Hand C; Spiehler V
J Forensic Sci; 2005 Jul; 50(4):928-32. PubMed ID: 16078500
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity and specificity of the Cozart microplate EIA cocaine oral fluid at proposed screening and confirmation cutoffs.
Kim I; Barnes AJ; Schepers R; Moolchan ET; Wilson L; Cooper G; Reid C; Hand C; Huestis MA
Clin Chem; 2003 Sep; 49(9):1498-503. PubMed ID: 12928231
[TBL] [Abstract][Full Text] [Related]
9. Validation of an ELISA-based screening assay for the detection of amphetamine, MDMA and MDA in blood and oral fluid.
Laloup M; Tilman G; Maes V; De Boeck G; Wallemacq P; Ramaekers J; Samyn N
Forensic Sci Int; 2005 Oct; 153(1):29-37. PubMed ID: 15922530
[TBL] [Abstract][Full Text] [Related]
10. Determination of opiates and cocaine in hair using automated enzyme immunoassay screening methodologies followed by gas chromatographic-mass spectrometric (GC-MS) confirmation.
Lachenmeier K; Musshoff F; Madea B
Forensic Sci Int; 2006 Jun; 159(2-3):189-99. PubMed ID: 16203118
[TBL] [Abstract][Full Text] [Related]
11. Blind trials of an onsite saliva drug test for marijuana and opiates.
Jehanli A; Brannan S; Moore L; Spiehler VR
J Forensic Sci; 2001 Sep; 46(5):1214-20. PubMed ID: 11569567
[TBL] [Abstract][Full Text] [Related]
12. Gas chromatography-mass spectrometry confirmation of Cozart RapiScan saliva methadone and opiates tests.
Moore L; Wicks J; Spiehler V; Holgate R
J Anal Toxicol; 2001 Oct; 25(7):520-4. PubMed ID: 11599594
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Cozart DDSV test for cannabis in oral fluid.
Kintz P; Brunet B; Muller JF; Serra W; Villain M; Cirimele V; Mura P
Ther Drug Monit; 2009 Feb; 31(1):131-4. PubMed ID: 19155965
[TBL] [Abstract][Full Text] [Related]
14. Use of gas chromatography/mass spectrometry with positive chemical ionization for the determination of opiates in human oral fluid.
Cámpora P; Bermejo AM; Tabernero MJ; Fernández P
Rapid Commun Mass Spectrom; 2006; 20(8):1288-92. PubMed ID: 16548052
[TBL] [Abstract][Full Text] [Related]
15. Screening postmortem whole blood for oxycodone by ELISA response ratios.
Spiehler VR; DeCicco L; McCutcheon JR; Kupiec T; Kemp P
J Forensic Sci; 2004 May; 49(3):621-6. PubMed ID: 15171187
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the IDS One-Step ELISA kits for the detection of illicit drugs in hair.
Pujol ML; Cirimele V; Tritsch PJ; Villain M; Kintz P
Forensic Sci Int; 2007 Aug; 170(2-3):189-92. PubMed ID: 17628371
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of multiple illicit drugs in preserved oral fluid by solid-phase extraction and liquid chromatography-tandem mass spectrometry.
Wood M; Laloup M; Ramirez Fernandez Mdel M; Jenkins KM; Young MS; Ramaekers JG; De Boeck G; Samyn N
Forensic Sci Int; 2005 Jun; 150(2-3):227-38. PubMed ID: 15944064
[TBL] [Abstract][Full Text] [Related]
18. Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testing.
Huestis MA; Cone EJ; Wong CJ; Umbricht A; Preston KL
J Anal Toxicol; 2000 Oct; 24(7):509-21. PubMed ID: 11043653
[TBL] [Abstract][Full Text] [Related]
19. Laboratory evaluation and field application of roadside oral fluid collectors and drug testing devices.
Crouch DJ; Walsh JM; Cangianelli L; Quintela O
Ther Drug Monit; 2008 Apr; 30(2):188-95. PubMed ID: 18367979
[TBL] [Abstract][Full Text] [Related]
20. Integration of GC/EI-MS and GC/NCI-MS for simultaneous quantitative determination of opiates, amphetamines, MDMA, ketamine, and metabolites in human hair.
Wu YH; Lin KL; Chen SC; Chang YZ
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):192-202. PubMed ID: 18585989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
